Patients Expected Profemur Artificial Hips to Last. Then They Snapped in Half.
(By Brett Kelman and Anna Werner, CBS News and KFF Health News) Bradley Little, a physical education teacher in Arizona,
Read More
FDA
Manufacturers need to be more open about a dangerous Alzheimer’s drug side effect
(By Madhav Thambisetty for STAT) Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover
Read MoreSen. Sanders pushes NIH to rein in drug prices
(By Sydney Lupkin for NPR) Can the National Institutes of Health bring down drug prices? It doesn’t approve new medicines
Read MoreDoubts Abound About a New Alzheimer’s Blood Test
(By Judith Graham for KFF Health News) For the first time, people worried about their risk of Alzheimer’s disease can
Read MoreNew Alzheimer’s Drug Raises Hopes — Along With Questions
(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read MoreNew ALS medication offers hope
(Source – news.va.gov) A Marine Corps Veteran got an infusion of hope this week when he became the second patient
Read MoreKFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs
(By Alex Montero, Grace Sparks, Ashley Kirzinger, Isabelle Valdes, and Liz Hamel for Kaiser Family Foundation Published: Aug 04, 2023)
Read MoreAn experimental Alzheimer’s drug outperforms one just approved by the FDA
(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer’s may soon have a new option to stave
Read MoreWill the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read MoreLeqembi could cost Medicare up to $17.8B
(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read More